BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 778963)

  • 21. Effect of alpha receptor blocking drug, thymoxamine, on allergen induced bronchoconstriction in extrinsic asthma.
    Patel KR; Kerr JW
    Clin Allergy; 1975 Sep; 5(3):311-6. PubMed ID: 126824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Die therapeutischen Grundlagen des exogen-allergisch ausgelösten Bronchospasmus].
    Kummer F
    Wien Klin Wochenschr; 1976 Oct; 88(20):669-74. PubMed ID: 136812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibitory effect of disodium cromoglycate (Lomudal) inhalation antigen provocation in atopic asthma; result of a single-blind trial].
    Wüthrich B
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1034-8. PubMed ID: 5003909
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide.
    Polosa R; Lau LC; Holgate ST
    Eur Respir J; 1990 Jun; 3(6):665-72. PubMed ID: 2199209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma.
    Hansel TT; Neighbour H; Erin EM; Tan AJ; Tennant RC; Maus JG; Barnes PJ
    Chest; 2005 Oct; 128(4):1974-9. PubMed ID: 16236844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanisms of bronchospasm in experimental microbial sensitization. I. Immunological stage.
    Beklemishev ND; Belyaev NN; Sukhodoeva GS; Bulvakhter YL
    Allergol Immunopathol (Madr); 1984; 12(2):129-34. PubMed ID: 6464938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled and oral salbutamol in exercise-induced asthma.
    Anderson SD; Seale JP; Rozea P; Bandler L; Theobald G; Lindsay DA
    Am Rev Respir Dis; 1976 Sep; 114(3):493-500. PubMed ID: 970730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind crossover study on the protective effect of fenoterol--administered by pressurized aerosol and in powder form--in allergen-induced asthma.
    D'Amato G; Schiano M; Cocco G; Melillo G
    Respiration; 1984; 45(3):276-80. PubMed ID: 6379789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral application of calcium and vitamin D2 in allergic bronchial asthma (author's transl)].
    Utz G; Hauck AM
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1395-8. PubMed ID: 825744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the protective effects of nifedipine and verapamil in patients with bronchial hyperreactivity].
    Malinowski R; Wasek Z; Frank-Piskorska A
    Wiad Lek; 1989 Feb; 42(3):129-33. PubMed ID: 2696203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New drug evaluation using exercise-induced bronchospasm.
    Sprenkle AC; VanArsdel PP; Biermann CW
    Pediatrics; 1975 Nov; 56(5 pt-2 suppl):937-9. PubMed ID: 1187285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of oral zindotrine (MDL-257), a bronchial smooth muscle relaxant, on histamine airways responsiveness in asymptomatic asthmatics.
    Küng M; Bangs SE; Gordon EE; Barker KB; Diamond L
    Ann Allergy; 1987 Sep; 59(3):201-6. PubMed ID: 3307547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of fog-induced bronchospasm by high doses of ipratropium bromide in asthmatics.
    Simone P; Robuschi M; Vaghi A; Fasano W; Bianco S
    Respiration; 1986; 50 Suppl 2():209-11. PubMed ID: 2951808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of respiratory allergy in provoking reversible bronchial obstruction.
    Hałuszka J; Brański H; Sciślicki A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):731-4. PubMed ID: 749829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon as a bronchospastic factor in patients with bronchial asthma].
    Krasnowska M; Małolepszy J; Liebhart E
    Pneumonol Alergol Pol; 1992; 60(7-8):22-5. PubMed ID: 1493514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement in allergen-induced bronchospasm in house-dust RAST negative asthmatic patients.
    Alam R; Rozniecki J; Swatko A; Kuzminska B
    Allergol Immunopathol (Madr); 1983; 11(6):431-3. PubMed ID: 6670660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of nifedipine and diltiazem on methacholine-induced bronchospasm in allergic asthma.
    Ferrari M; Olivieri M; De Gasperi M; Lechi A
    Ann Allergy; 1989 Sep; 63(3):196-200. PubMed ID: 2672909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
    Boot JD; de Haas S; Tarasevych S; Roy C; Wang L; Amin D; Cohen J; Sterk PJ; Miller B; Paccaly A; Burggraaf J; Cohen AF; Diamant Z
    Am J Respir Crit Care Med; 2007 Mar; 175(5):450-7. PubMed ID: 17170385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, functional and pathogenetic aspects of bronchial reactivity to prostaglandins F2alpha, E1, and E2.
    Pasargiklian M; Bianco S; Allegra L
    Adv Prostaglandin Thromboxane Res; 1976; 1():461-75. PubMed ID: 136876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.